Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19

Increased rates of anxiety and depression have been reported for older adults during the COVID-19 pandemic. However, little is known regarding the onset of mental health morbidity during the acute phase of the disease and the role of age as potential independent risk factor for psychiatric symptoms. The cross-sectional association between older age and psychiatric symptoms has been estimated in a sample of 130 patients hospitalized for COVID-19 during the first and second wave of the pandemic. Compared to younger patients, those who were 70 years of age or older resulted at a higher risk of psychiatric symptoms measured on the Brief Psychiatric Symptoms Rating Scale (BPRS) (adjusted (adj.) odds ratio (OR) 2.36, 95% confidence interval (CI) 1.05–5.30) and delirium (adj. OR 5.24, 95% CI 1.63–16.8)). No association was found between older age and depressive symptoms or anxiety. Age was associated with psychiatric symptoms independently of gender, marital status, history of psychiatric illness, severity of disease and cardiovascular morbidity. Older adults appear at high risk of developing psychiatric symptoms related to COVID-19 disease during hospital stay. Multidisciplinary preventive and therapeutic interventions should be implemented to reduce the risk of psychiatric morbidity and related adverse health care outcomes among older hospital inpatients with COVID-19.

[1]  D. Jeste,et al.  Mental health care for older adults: recent advances and new directions in clinical practice and research , 2022, World psychiatry : official journal of the World Psychiatric Association.

[2]  E. Seifritz,et al.  Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale , 2022, Psychiatry Research.

[3]  F. Landi COVID-19 in the Geriatric Patient , 2022, Clinics in Geriatric Medicine.

[4]  R. Ghomi,et al.  Delirium as a Presenting Symptom of COVID–19 , 2022, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[5]  Yu-Hui Liu,et al.  One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. , 2022, JAMA neurology.

[6]  R. Bernabei,et al.  Models of hospital care during COVID-19 pandemic in Italy: results from a survey of physicians , 2022, Journal of Gerontology and Geriatrics.

[7]  M. L. Cristina,et al.  Role of SatO2, PaO2/FiO2 Ratio and PaO2 to Predict Adverse Outcome in COVID-19: A Retrospective, Cohort Study , 2021, International journal of environmental research and public health.

[8]  C. Williamson,et al.  Incidence, Predictors and Outcomes of Delirium in Critically Ill Patients With COVID-19 , 2021, The Neurohospitalist.

[9]  I. Wurster,et al.  Impaired Executive Function and Depression as Independent Risk Factors for Reported Delirium Symptoms: An Observational Cohort Study Over 8 Years , 2021, Frontiers in Aging Neuroscience.

[10]  A. Seidler,et al.  The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis , 2021, BMJ Global Health.

[11]  G. Lorenzo,et al.  Stressful Life Events and Resilience During the COVID-19 Lockdown Measures in Italy: Association With Mental Health Outcomes and Age , 2021, Frontiers in Psychiatry.

[12]  Fanyang Kong,et al.  Effect of Psychological–Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients , 2020, Frontiers in Psychiatry.

[13]  J. Pell,et al.  Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants , 2020, PloS one.

[14]  G. Mosayebi,et al.  Cytokine profile and disease severity in patients with COVID-19 , 2020, Cytokine.

[15]  R. Gur,et al.  Resilience, COVID-19-related stress, anxiety and depression during the pandemic in a large population enriched for healthcare providers , 2020, Translational Psychiatry.

[16]  Mark E. Howard,et al.  Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[17]  F. Piras,et al.  Predominant polarity and hippocampal subfield volumes in Bipolar disorders , 2020, Bipolar disorders.

[18]  R. Thangavel,et al.  COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation , 2020, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[19]  Lijun Ding,et al.  Factors related to mental health of inpatients with COVID-19 in Wuhan, China , 2020, Brain, Behavior, and Immunity.

[20]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[21]  N. Salari,et al.  Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis , 2020, Globalization and Health.

[22]  M. Modat,et al.  Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults , 2020, medRxiv.

[23]  Paolo Fusar-Poli,et al.  Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic , 2020, The Lancet Psychiatry.

[24]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[25]  K. Matthews,et al.  Sleep characteristics and inflammatory biomarkers among midlife women , 2018, Sleep.

[26]  James R. Johnson,et al.  Delirium in Hospitalized Older Adults. , 2018, The New England journal of medicine.

[27]  C. Rapinesi,et al.  Neurobiological Evidence for the Primacy of Mania Hypothesis , 2017, Current neuropharmacology.

[28]  S. Musich,et al.  The impact of resilience among older adults. , 2016, Geriatric nursing.

[29]  V. Arolt,et al.  Deficiencies of the T and natural killer cell system in major depressive disorder T regulatory cell defects are associated with inflammatory monocyte activation , 2016, Brain, Behavior, and Immunity.

[30]  E. Thompson Hamilton Rating Scale for Anxiety (HAM-A). , 2015, Occupational medicine.

[31]  B. Nair,et al.  Delirium in the elderly: a review. , 2008, Oman medical journal.

[32]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[33]  V. Neelon,et al.  The NEECHAM Confusion Scale: construction, validation, and clinical testing. , 1996, Nursing research.

[34]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[35]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[36]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.